Exchange Traded Concepts’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,584
| Closed | -$71.9K | – | 1173 |
|
|
2022
Q4 | $71.9K | Buy |
2,584
+408
| +19% | +$11.3K | ﹤0.01% | 802 |
|
|
2022
Q3 | $67K | Buy |
2,176
+302
| +16% | +$9.3K | ﹤0.01% | 794 |
|
|
2022
Q2 | $55K | Buy |
1,874
+1,382
| +281% | +$40.6K | ﹤0.01% | 899 |
|
|
2022
Q1 | $16K | Buy |
+492
| New | +$16K | ﹤0.01% | 1055 |
|
|
2021
Q2 | – | Sell |
-125
| Closed | -$7K | – | 1136 |
|
|
2021
Q1 | $7K | Sell |
125
-380
| -75% | -$21.3K | ﹤0.01% | 1007 |
|
|
2020
Q4 | $42K | Buy |
+505
| New | +$42K | ﹤0.01% | 756 |
|